10.42USD+0.19%Mkt Cap: 93.53M USDP/E: —Last update: 2026-06-01
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleuce…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap93.53M USD
Enterprise Value95.41M USD
Revenue (TTM)23.14M USD
Gross Profit99.56M USD
Net Income (TTM)32.69M USD
Revenue/Share1.730 USD
Last Price10.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0465131078
Valuation
P/E (Trailing)—
P/E (Forward)6.42
PEG—
EV/EBITDA12.47
EV/Revenue4.12
P/S4.09
P/B-2.40
EPS (TTM)-1.22
EPS (Forward)1.64
52W Range
3.92043% of range19.14
52W High19.14 USD
52W Low3.920 USD
Profitability
Gross Margin82.44%
Oper. Margin-652.91%
EBITDA Margin33.06%
Profit Margin27.07%
ROE-84.90%
ROA161.54%
Growth
Revenue Growth-99.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-50.94M USD
CapEx (TTM)—
FCF Margin-27.62%
FCF Yield-6.83%
Net Debt716.00K USD
Net Debt/EBITDA0.09
Balance Sheet
Debt/Equity-0.27
Current Ratio2.16
Quick Ratio1.48
Book Value/Sh-4.3830 USD
Cash/Share0.9280 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 20, 2024
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)13.67 USD
Target Range10.00 USD – 18.00 USD
# Analysts3
Ownership
Shares Out.9.01M
Float4.74M
Insiders16.66%
Institutions52.46%
Short Interest
Short Ratio0.1d
Short % Float8.64%
Short % Out.6.07%
Shares Short546.47K
Short (prev mo.)317.95K
Technical
SMA 506.342 (+64.3%)
SMA 20010.15 (+2.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)2.85M
Avg Vol (10d)195.14K
Technical Indicators
RSI (14)65.1
MACD1.1886
MACD Signal1.1277
MACD Hist.+0.0609
BB Upper12.75 USD
BB Middle8.701 USD
BB Lower4.655 USD
BB Width92.99%
ATR (14)1.015 USD
Vol Ratio (20d)0.02x